173 related articles for article (PubMed ID: 3630591)
1. In vitro diagnosis of susceptibility to malignant hyperthermia: evaluation of tests with halothane-caffeine, potassium chloride, suxamethonium and caffeine-suxamethonium.
Ording H; Skovgaard LT
Acta Anaesthesiol Scand; 1987 Jul; 31(5):462-5. PubMed ID: 3630591
[TBL] [Abstract][Full Text] [Related]
2. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
Ording H; Bendixen D
Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
[TBL] [Abstract][Full Text] [Related]
3. Influence of propranolol on the in vitro response to caffeine and halothane in malignant hyperthermia-susceptible muscle.
Ording H
Acta Anaesthesiol Scand; 1989 Jul; 33(5):405-8. PubMed ID: 2800978
[TBL] [Abstract][Full Text] [Related]
4. Influence of salbutamol on the in vitro muscle response to caffeine and halothane in malignant hyperthermia.
Bendixen D; Ording H
Acta Anaesthesiol Scand; 1990 Nov; 34(8):658-61. PubMed ID: 2275327
[TBL] [Abstract][Full Text] [Related]
5. Identification of susceptibility to malignant hyperpyrexia in swine.
Okumura F; Crocker BD; Denborough MA
Br J Anaesth; 1979 Mar; 51(3):171-6. PubMed ID: 435338
[TBL] [Abstract][Full Text] [Related]
6. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.
Hartung E; Koob M; Anetseder M; Schoemig P; Krauspe R; Hogrefe G; Engelhardt W
Acta Anaesthesiol Scand; 1996 Apr; 40(4):437-44. PubMed ID: 8738688
[TBL] [Abstract][Full Text] [Related]
7. In vitro diagnosis of susceptibility to malignant hyperthermia: comparison between dynamic and static halothane and caffeine tests.
Ording H; Skovgaard LT
Acta Anaesthesiol Scand; 1987 Jul; 31(5):458-61. PubMed ID: 3630590
[TBL] [Abstract][Full Text] [Related]
8. 4-Chloro-m-cresol test--a possible supplementary test for diagnosis of malignant hyperthermia susceptibility.
Ording H; Glahn K; Gardi T; Fagerlund T; Bendixen D
Acta Anaesthesiol Scand; 1997 Sep; 41(8):967-72. PubMed ID: 9311392
[TBL] [Abstract][Full Text] [Related]
9. Static v. dynamic tests in the in vitro diagnosis of malignant hyperthermia susceptibility.
Ranklev E; Fletcher R; Blomquist S
Br J Anaesth; 1986 Jun; 58(6):646-8. PubMed ID: 3707802
[TBL] [Abstract][Full Text] [Related]
10. In vitro muscle contractures induced by halothane and suxamethonium. II: Human skeletal muscle from normal and malignant hyperthermia susceptible patients.
Fletcher JE; Rosenberg H
Br J Anaesth; 1986 Dec; 58(12):1433-9. PubMed ID: 3790395
[TBL] [Abstract][Full Text] [Related]
11. Temperature dependence of muscle function in malignant hyperpyrexia-susceptible swine.
Sullivan JS; Denborough MA
Br J Anaesth; 1981 Nov; 53(11):1217-22. PubMed ID: 7326167
[TBL] [Abstract][Full Text] [Related]
12. Classification of malignant hyperthermia-equivocal patients by 4-chloro-M-cresol.
Gilly H; Musat I; Fricker R; Bittner RE; Steinbereithner K; Kress HG
Anesth Analg; 1997 Jul; 85(1):149-54. PubMed ID: 9212139
[TBL] [Abstract][Full Text] [Related]
13. An analysis of the predictive probability of the in vitro contracture test for determining susceptibility to malignant hyperthermia.
Hopkins PM; Ellis FR; Halsall PJ; Stewart AD
Anesth Analg; 1997 Mar; 84(3):648-56. PubMed ID: 9052318
[TBL] [Abstract][Full Text] [Related]
14. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group.
Br J Anaesth; 1984 Nov; 56(11):1267-9. PubMed ID: 6487446
[TBL] [Abstract][Full Text] [Related]
15. Is the "K-type" caffeine-halothane responder susceptible to malignant hyperthermia?
Ellis FR; Halsall PJ; Hopkins PM
Br J Anaesth; 1992 Nov; 69(5):468-70. PubMed ID: 1467078
[TBL] [Abstract][Full Text] [Related]
16. In vitro interaction between halothane and succinylcholine in human skeletal muscle: implications for malignant hyperthermia and masseter muscle rigidity.
Fletcher JE; Rosenberg H
Anesthesiology; 1985 Aug; 63(2):190-4. PubMed ID: 4025868
[TBL] [Abstract][Full Text] [Related]
17. Use of the calcium agonist BAY K 8644 for in vitro diagnosis of susceptibility to malignant hyperthermia.
Adnet PJ; Krivosic-Horber RM; Haudecoeur G; Adamantidis MM; Reyford GH; Imbenotte M; Cordonnier C
Br J Anaesth; 1990 Dec; 65(6):791-5. PubMed ID: 1702303
[TBL] [Abstract][Full Text] [Related]
18. [The action of ketamine on muscle contractile behavior. In vitro studies on the musculature of subjects susceptible to malignant hyperthermia].
Hackl W; Winkler M; Mauritz W; Steinbereithner K
Anaesthesist; 1989 Dec; 38(12):681-5. PubMed ID: 2619030
[TBL] [Abstract][Full Text] [Related]
19. Inositol 1,4,5-trisphosphate synthesis in mononuclear white blood cells of malignant hyperthermia-susceptible and normal human beings, following in vitro exposure to halothane, caffeine and ryanodine.
Martens U; Krause T; Scholz J; Wappler F; Steinrücke K; am Esch JS
Eur J Anaesthesiol; 2000 Jun; 17(6):364-72. PubMed ID: 10928436
[TBL] [Abstract][Full Text] [Related]
20. Genetic effects on the variability of the halothane and caffeine muscle contracture tests.
Urwyler A; Censier K; Kaufmann MA; Drewe J
Anesthesiology; 1994 Jun; 80(6):1287-95. PubMed ID: 8010475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]